S

Semaglutide

Tool / Product

GLP-1 receptor agonist used for diabetes and obesity; long-acting variants lead to sustained appetite suppression; approved 2005 (diabetes) and 2014 (obesity).

Mentioned in 1 video

Diabetes_RiskWeight_Loss
The Uncomfortable Truth About Ozempic

The Uncomfortable Truth About Ozempic

Kurzgesagt – In a Nutshell

GLP-1 receptor agonist used for diabetes and obesity; long-acting variants lead to sustained appetite suppression; approved 2005 (diabetes) and 2014 (obesity).